HPV Vaccination

About the HPV Vaccination

Human papillomavirus (HPV) is the most common sexually transmitted infection in the UK, with most sexually active people exposed at some point in their lives. The majority of HPV infections clear spontaneously, but persistent infection with high-risk strains — particularly HPV 16 and 18 — can cause cervical, oropharyngeal, anal, vulval, vaginal, and penile cancers. Low-risk strains (HPV 6 and 11) cause genital warts.

The HPV vaccine (Gardasil 9) protects against nine HPV strains responsible for approximately 90% of cervical cancers and the majority of other HPV-related cancers and genital warts. It is most effective when given before the onset of sexual activity, but provides meaningful protection at any age. The NHS offers HPV vaccination to girls and boys aged 12 to 13; private vaccination is available at The Vesey for older adolescents and adults outside the NHS programme.

Who should have this vaccination?

• Individuals aged 9 and over who have not previously received the HPV vaccine
• Those who did not receive the vaccine through the NHS school programme
• Adults seeking protection — vaccination is beneficial even after some HPV exposure, as it protects against strains not yet encountered
• Men who have sex with men, who are not covered by the routine NHS programme in all circumstances
• Immunocompromised individuals, including those living with HIV
• Women aged 25 to 45 who wish to supplement their cervical screening programme

Vaccination schedule

For individuals aged 9 to 14, a two-dose schedule is recommended, with the second dose given 6 to 12 months after the first. For those aged 15 and over, or for immunocompromised individuals of any age, a three-dose schedule is required at 0, 1 to 2 months, and 6 months. All doses should be with the same vaccine brand. Our clinical team will confirm the appropriate schedule at your appointment.